Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Embody vs Gala Health

By Dana Whitfield · Updated October 2026

Embody is easier to compare from its published one-month product prices. Gala deserves a checkout-specific comparison because its campaign and longer-term pages show different offers. I would not prepay Gala from a headline alone.

Consider Embody if the short-plan price is decisive

The current one-month injection listings are $79/$129. The annual equivalents require full prepaid purchases, and payment finality is strict. Establish the actual supply period and cancellation deadline before choosing a longer term.

Read the Embody review →

Consider Gala after resolving the selected offer

A campaign lists $129 semaglutide and $179 tirzepatide with no-contract wording, while other pages describe yearly and three-month terms. Ask for the complete amount, charge schedule and refund boundary for the actual plan you are offered.

Read the Gala Health review →
Payment and renewal details

Embody

Monthly plan
$79 semaglutide / $129 tirzepatide per month; compounded injections
Annual prepayment
$828 semaglutide / $1,428 tirzepatide for 12 months upfront; auto-renews
Supply period
Month and week descriptions differ; confirm dose, quantity and actual days
Cancellation
auto-renews; At least 72 hours before renewal; payment generally nonrefundable

Gala Health

Advertised offers
12-month plan $179/month; 3-month FAQ $199/month; campaign from $129 / $179 per month
Complete bill
Price and commitment presentations conflict; selected checkout unresolved
Supply period
Exact preparation, quantity and duration unverified
Cancellation
At least 72 hours before billing; ordinary cancellation does not create a refund

A conflicting advertised price is not a verified monthly purchase. Neither a named care network nor a general pharmacy statement establishes the clinician and dispensing pharmacy assigned to a particular order.

Embody
Site position #52

Lower grade

Gala Health
Site position #12

Higher grade

Score comparison

Gala Health has the higher recorded score — 82.9/100 to 76.5/100.

Gala Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Gala offers low advertised injection prices and a branded Ozempic path, but its campaign and longer-term plan pages need to be reconciled before paying.

Visit Embody ↗Visit Gala Health ↗

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueEmbody +4
88
84
Dose & formulationEven
83
83
Clinical oversightGala Health +2
83
85
Labs & monitoringGala Health +29
54
83
FulfillmentEmbody +5
93
88
Contract termsGala Health +41
25
66
Embody · top barGala Health · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricEmbodyGala Health
WeighScore76.5/10082.9/100
GradeCB−
Site position#52#12
Semaglutide$79/mo (one-month injection; $828 annual prepay equals $69/mo)From $129/mo (campaign; plan pages conflict—confirm billing term)
Tirzepatide$129/mo (one-month injection; $1,428 annual prepay equals $119/mo)From $179/mo (campaign; yearly and three-month offers conflict—confirm term)
CoverageState eligibility not fully published; confirm your locationCoverage wording differs: all 50 on homepage, most U.S. states in campaign
Brand-name accessNot confirmedYes
Oral / sublingualNot confirmedNot confirmed
Embody

Site position #52 · C

Strengths

  • One-month injection offers at $79 semaglutide and $129 tirzepatide
  • Separate monthly, three-, six- and twelve-month price tiers published
  • OpenLoop care network and four pharmacy partners publicly named; individual assignment still needs confirmation

What to consider

  • Payments are described as final at purchase except provider-initiated medical disqualification, with used services deducted
  • Cancel at least 72 hours before renewal; unused prepaid months are not routinely refundable
  • Homepage week counts differ from product month labels; confirm supply and charge dates
  • Current catalog supports injections; no active oral-gum offer or universal state footprint confirmed
Gala Health

Site position #12 · B−

Strengths

  • Campaign advertises $129 semaglutide and $179 tirzepatide with medication and telehealth visits included if prescribed
  • Brand-name Ozempic path and broader menopause/HRT services listed
  • Terms identify clinical practice networks; actual clinician and pharmacy assignment still need checking

What to consider

  • Yearly, three-month and no-contract campaign presentations differ; do not assume an annual upfront charge or flat month-to-month terms
  • Cancel at least 72 hours before renewal; ordinary cancellation does not produce a refund
  • Medical-disqualification refund wording differs between full-refund and remaining/current-cycle provisions
  • Dispensing pharmacy not identified for an individual order; oral option is a waitlist, not a current offer

Featured provider

Gala Health

Gala Health scores 82.9/100 (B−). Gala offers low advertised injection prices and a branded Ozempic path, but its campaign and longer-term plan pages need to be reconciled before paying.

Commercial relationships affect this placement. The score comparison above is separate.

Visit Gala Health ↗Read the Gala Health review →
Alternatives to Embody →Alternatives to Gala Health →All comparisons →

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard